Although identical miRNAs were not detected, several pathways relevant for cancer (such as acute myeloid leukaemia, chronic myeloid leukaemia, mTOR signalling) or signal transduction processes altered by IR (such as FoxO signalling, Hippo signalling, MAPK signalling, TGF-beta signalling) were in common. The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.